Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Enterohemorrhagic E. coli (EHEC)-Secreted Serine Protease EspP Stimulates Electrogenic Ion Transport in Human Colonoid Monolayers.

Tse CM, In JG, Yin J, Donowitz M, Doucet M, Foulke-Abel J, Ruiz-Perez F, Nataro JP, Zachos NC, Kaper JB, Kovbasnjuk O.

Toxins (Basel). 2018 Sep 1;10(9). pii: E351. doi: 10.3390/toxins10090351.

2.

Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations.

Roxas JL, Monasky RC, Roxas BAP, Agellon AB, Mansoor A, Kaper JB, Vedantam G, Viswanathan VK.

Cell Mol Gastroenterol Hepatol. 2018 Apr 27;6(2):163-180. doi: 10.1016/j.jcmgh.2018.04.007. eCollection 2018.

3.

Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.

Runte CS, Jain U, Getz LJ, Secord S, Kuwae A, Abe A, LeBlanc JJ, Stadnyk AW, Kaper JB, Hansen AM, Thomas NA.

Mol Microbiol. 2018 Jun;108(5):536-550. doi: 10.1111/mmi.13948. Epub 2018 Mar 30.

PMID:
29509331
4.

Phosphotyrosine-Mediated Regulation of Enterohemorrhagic Escherichia coli Virulence.

Robertson CD, Hazen TH, Kaper JB, Rasko DA, Hansen AM.

MBio. 2018 Feb 27;9(1). pii: e00097-18. doi: 10.1128/mBio.00097-18.

5.

Enterotoxigenic Escherichia coli is phagocytosed by macrophages underlying villus-like intestinal epithelial cells: modeling ex vivo innate immune defenses of the human gut.

Noel G, Doucet M, Nataro JP, Kaper JB, Zachos NC, Pasetti MF.

Gut Microbes. 2017 Oct 31:0. doi: 10.1080/19490976.2017.1398871. [Epub ahead of print]

6.

PaxVax CVD 103-HgR single-dose live oral cholera vaccine.

Levine MM, Chen WH, Kaper JB, Lock M, Danzig L, Gurwith M.

Expert Rev Vaccines. 2017 Mar;16(3):197-213. doi: 10.1080/14760584.2017.1291348. Review.

PMID:
28165831
7.

Editorial: Infection and immunity research at the University of Maryland, Baltimore.

Kaper JB, Flajnik MF, Mobley HL.

Pathog Dis. 2016 Nov;74(8). pii: ftw100. Epub 2016 Oct 4. No abstract available.

PMID:
27702794
8.

Genomic diversity of EPEC associated with clinical presentations of differing severity.

Hazen TH, Donnenberg MS, Panchalingam S, Antonio M, Hossain A, Mandomando I, Ochieng JB, Ramamurthy T, Tamboura B, Qureshi S, Quadri F, Zaidi A, Kotloff KL, Levine MM, Barry EM, Kaper JB, Rasko DA, Nataro JP.

Nat Microbiol. 2016 Jan 18;1:15014. doi: 10.1038/nmicrobiol.2015.14.

9.

Enterohemorrhagic Escherichia coli reduce mucus and intermicrovillar bridges in human stem cell-derived colonoids.

In J, Foulke-Abel J, Zachos NC, Hansen AM, Kaper JB, Bernstein HD, Halushka M, Blutt S, Estes MK, Donowitz M, Kovbasnjuk O.

Cell Mol Gastroenterol Hepatol. 2016 Jan 1;2(1):48-62.e3.

10.

Comparative Genomics Provides Insight into the Diversity of the Attaching and Effacing Escherichia coli Virulence Plasmids.

Hazen TH, Kaper JB, Nataro JP, Rasko DA.

Infect Immun. 2015 Oct;83(10):4103-17. doi: 10.1128/IAI.00769-15. Epub 2015 Aug 3.

11.

RNA-Seq analysis of isolate- and growth phase-specific differences in the global transcriptomes of enteropathogenic Escherichia coli prototype isolates.

Hazen TH, Daugherty SC, Shetty A, Mahurkar AA, White O, Kaper JB, Rasko DA.

Front Microbiol. 2015 Jun 12;6:569. doi: 10.3389/fmicb.2015.00569. eCollection 2015.

12.

Overview and Historical Perspectives.

Kaper JB, O'Brien AD.

Microbiol Spectr. 2014 Dec;2(6). doi: 10.1128/microbiolspec.EHEC-0028-2014. Review.

13.

The presence of the pAA plasmid in the German O104:H4 Shiga toxin type 2a (Stx2a)-producing enteroaggregative Escherichia coli strain promotes the translocation of Stx2a across an epithelial cell monolayer.

Boisen N, Hansen AM, Melton-Celsa AR, Zangari T, Mortensen NP, Kaper JB, O'Brien AD, Nataro JP.

J Infect Dis. 2014 Dec 15;210(12):1909-19. doi: 10.1093/infdis/jiu399. Epub 2014 Jul 18.

14.

H-NST induces LEE expression and the formation of attaching and effacing lesions in enterohemorrhagic Escherichia coli.

Levine JA, Hansen AM, Michalski JM, Hazen TH, Rasko DA, Kaper JB.

PLoS One. 2014 Jan 21;9(1):e86618. doi: 10.1371/journal.pone.0086618. eCollection 2014.

15.

Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epithelium.

In J, Lukyanenko V, Foulke-Abel J, Hubbard AL, Delannoy M, Hansen AM, Kaper JB, Boisen N, Nataro JP, Zhu C, Boedeker EC, Girón JA, Kovbasnjuk O.

PLoS One. 2013 Jul 18;8(7):e69196. doi: 10.1371/journal.pone.0069196. Print 2013.

16.

The Escherichia coli phosphotyrosine proteome relates to core pathways and virulence.

Hansen AM, Chaerkady R, Sharma J, Díaz-Mejía JJ, Tyagi N, Renuse S, Jacob HK, Pinto SM, Sahasrabuddhe NA, Kim MS, Delanghe B, Srinivasan N, Emili A, Kaper JB, Pandey A.

PLoS Pathog. 2013;9(6):e1003403. doi: 10.1371/journal.ppat.1003403. Epub 2013 Jun 13.

17.

Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo.

Faherty CS, Harper JM, Shea-Donohue T, Barry EM, Kaper JB, Fasano A, Nataro JP.

PLoS One. 2012;7(11):e49980. doi: 10.1371/journal.pone.0049980. Epub 2012 Nov 16. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/44400281-2456-4853-a89b-4dea4f9aa27b. Faherty, Christina [corrected to Faherty, Christina S].

18.

The ribosome binding site of a mini-ORF protects a T3SS mRNA from degradation by RNase E.

Lodato PB, Hsieh PK, Belasco JG, Kaper JB.

Mol Microbiol. 2012 Dec;86(5):1167-82. doi: 10.1111/mmi.12050. Epub 2012 Oct 12.

19.

In vivo bioluminescence imaging of Escherichia coli O104:H4 and role of aerobactin during colonization of a mouse model of infection.

Torres AG, Cieza RJ, Rojas-Lopez M, Blumentritt CA, Souza CS, Johnston RK, Strockbine N, Kaper JB, Sbrana E, Popov VL.

BMC Microbiol. 2012 Jun 20;12:112. doi: 10.1186/1471-2180-12-112.

20.

Contribution of urease to colonization by Shiga toxin-producing Escherichia coli.

Steyert SR, Kaper JB.

Infect Immun. 2012 Aug;80(8):2589-600. doi: 10.1128/IAI.00210-12. Epub 2012 Jun 4.

21.

Functional and phylogenetic analysis of ureD in Shiga toxin-producing Escherichia coli.

Steyert SR, Rasko DA, Kaper JB.

J Bacteriol. 2011 Feb;193(4):875-86. doi: 10.1128/JB.00922-10. Epub 2010 Dec 10.

22.

The LysR-type transcriptional regulator QseD alters type three secretion in enterohemorrhagic Escherichia coli and motility in K-12 Escherichia coli.

Habdas BJ, Smart J, Kaper JB, Sperandio V.

J Bacteriol. 2010 Jul;192(14):3699-712. doi: 10.1128/JB.00382-10. Epub 2010 May 21.

23.

The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.

Newton HJ, Pearson JS, Badea L, Kelly M, Lucas M, Holloway G, Wagstaff KM, Dunstone MA, Sloan J, Whisstock JC, Kaper JB, Robins-Browne RM, Jans DA, Frankel G, Phillips AD, Coulson BS, Hartland EL.

PLoS Pathog. 2010 May 13;6(5):e1000898. doi: 10.1371/journal.ppat.1000898.

24.

Effect on human cells of environmental Vibrio parahaemolyticus strains carrying type III secretion system 2.

Caburlotto G, Lleò MM, Hilton T, Huq A, Colwell RR, Kaper JB.

Infect Immun. 2010 Jul;78(7):3280-7. doi: 10.1128/IAI.00050-10. Epub 2010 May 17.

25.

Determination of spatial and temporal colonization of enteropathogenic E. coli and enterohemorrhagic E. coli in mice using bioluminescent in vivo imaging.

Rhee KJ, Cheng H, Harris A, Morin C, Kaper JB, Hecht G.

Gut Microbes. 2011 Jan-Feb;2(1):34-41. doi: 10.4161/gmic.2.1.14882.

26.

Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector.

Keller R, Hilton TD, Rios H, Boedeker EC, Kaper JB.

Microb Pathog. 2010 Jan;48(1):1-8. doi: 10.1016/j.micpath.2009.10.005. Epub 2009 Oct 28.

27.

Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR.

Morin CE, Kaper JB.

FEMS Immunol Med Microbiol. 2009 Oct;57(1):69-79. doi: 10.1111/j.1574-695X.2009.00580.x. Epub 2009 Jul 1.

28.

Hfq affects the expression of the LEE pathogenicity island in enterohaemorrhagic Escherichia coli.

Hansen AM, Kaper JB.

Mol Microbiol. 2009 Aug;73(3):446-65. doi: 10.1111/j.1365-2958.2009.06781.x. Epub 2009 Jun 29.

29.

The Escherichia coli ycbQRST operon encodes fimbriae with laminin-binding and epithelial cell adherence properties in Shiga-toxigenic E.  coli O157:H7.

Samadder P, Xicohtencatl-Cortes J, Saldaña Z, Jordan D, Tarr PI, Kaper JB, Girón JA.

Environ Microbiol. 2009 Jul;11(7):1815-26. doi: 10.1111/j.1462-2920.2009.01906.x. Epub 2009 Mar 11.

30.

The Escherichia coli common pilus and the bundle-forming pilus act in concert during the formation of localized adherence by enteropathogenic E. coli.

Saldaña Z, Erdem AL, Schüller S, Okeke IN, Lucas M, Sivananthan A, Phillips AD, Kaper JB, Puente JL, Girón JA.

J Bacteriol. 2009 Jun;191(11):3451-61. doi: 10.1128/JB.01539-08. Epub 2009 Feb 13.

31.

Synergistic role of curli and cellulose in cell adherence and biofilm formation of attaching and effacing Escherichia coli and identification of Fis as a negative regulator of curli.

Saldaña Z, Xicohtencatl-Cortes J, Avelino F, Phillips AD, Kaper JB, Puente JL, Girón JA.

Environ Microbiol. 2009 Apr;11(4):992-1006. doi: 10.1111/j.1462-2920.2008.01824.x. Epub 2009 Nov 14.

32.

The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection.

Schüller S, Lucas M, Kaper JB, Girón JA, Phillips AD.

Cell Microbiol. 2009 Mar;11(3):521-30. doi: 10.1111/j.1462-5822.2008.01275.x. Epub 2008 Dec 30.

33.

Post-transcriptional processing of the LEE4 operon in enterohaemorrhagic Escherichia coli.

Lodato PB, Kaper JB.

Mol Microbiol. 2009 Jan;71(2):273-90. doi: 10.1111/j.1365-2958.2008.06530.x. Epub 2008 Nov 4. Erratum in: Mol Microbiol. 2012 Jun;84(5):990.

34.

Vibrio cholerae flagellins induce Toll-like receptor 5-mediated interleukin-8 production through mitogen-activated protein kinase and NF-kappaB activation.

Harrison LM, Rallabhandi P, Michalski J, Zhou X, Steyert SR, Vogel SN, Kaper JB.

Infect Immun. 2008 Dec;76(12):5524-34. doi: 10.1128/IAI.00843-08. Epub 2008 Sep 22.

35.

The continuing evolution of a bacterial pathogen.

Kaper JB, Karmali MA.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4535-6. doi: 10.1073/pnas.0801435105. Epub 2008 Mar 19. No abstract available.

36.

An in vivo expression technology screen for Vibrio cholerae genes expressed in human volunteers.

Lombardo MJ, Michalski J, Martinez-Wilson H, Morin C, Hilton T, Osorio CG, Nataro JP, Tacket CO, Camilli A, Kaper JB.

Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18229-34. Epub 2007 Nov 6.

37.

Enteropathogenic Escherichia coli O125:H6 triggers attaching and effacing lesions on human intestinal biopsy specimens independently of Nck and TccP/TccP2.

Bai L, Schüller S, Whale A, Mousnier A, Marches O, Wang L, Ooka T, Heuschkel R, Torrente F, Kaper JB, Gomes TA, Xu J, Phillips AD, Frankel G.

Infect Immun. 2008 Jan;76(1):361-8. Epub 2007 Nov 5.

38.

Genetic diversity of the gene cluster encoding longus, a type IV pilus of enterotoxigenic Escherichia coli.

Gomez-Duarte OG, Chattopadhyay S, Weissman SJ, Giron JA, Kaper JB, Sokurenko EV.

J Bacteriol. 2007 Dec;189(24):9145-9. Epub 2007 Oct 19.

39.

Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7.

Xicohtencatl-Cortes J, Monteiro-Neto V, Ledesma MA, Jordan DM, Francetic O, Kaper JB, Puente JL, Girón JA.

J Clin Invest. 2007 Nov;117(11):3519-29. Erratum in: J Clin Invest. 2008 Feb;118(2):820.

40.

The possible influence of LuxS in the in vivo virulence of rabbit enteropathogenic Escherichia coli.

Zhu C, Feng S, Sperandio V, Yang Z, Thate TE, Kaper JB, Boedeker EC.

Vet Microbiol. 2007 Dec 15;125(3-4):313-22. Epub 2007 Jun 15.

41.

Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization.

Rendón MA, Saldaña Z, Erdem AL, Monteiro-Neto V, Vázquez A, Kaper JB, Puente JL, Girón JA.

Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10637-42. Epub 2007 Jun 11.

42.

LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains.

Zhu C, Feng S, Yang Z, Davis K, Rios H, Kaper JB, Boedeker EC.

Vaccine. 2007 Feb 26;25(10):1884-92. Epub 2006 Oct 27.

PMID:
17234305
43.

Shiga toxin binding in normal and inflamed human intestinal mucosa.

Schüller S, Heuschkel R, Torrente F, Kaper JB, Phillips AD.

Microbes Infect. 2007 Jan;9(1):35-9. Epub 2006 Dec 15.

PMID:
17208032
44.

Identification and characterization of "pathoadaptive mutations" of the cadBA operon in several intestinal Escherichia coli.

Jores J, Torres AG, Wagner S, Tutt CB, Kaper JB, Wieler LH.

Int J Med Microbiol. 2006 Dec;296(8):547-52. Epub 2006 Oct 4.

PMID:
17027337
45.

Nucleotide sequence analysis of the enteropathogenic Escherichia coli adherence factor plasmid pMAR7.

Brinkley C, Burland V, Keller R, Rose DJ, Boutin AT, Klink SA, Blattner FR, Kaper JB.

Infect Immun. 2006 Sep;74(9):5408-13.

46.

Long polar fimbriae and tissue tropism in Escherichia coli O157:H7.

Fitzhenry R, Dahan S, Torres AG, Chong Y, Heuschkel R, Murch SH, Thomson M, Kaper JB, Frankel G, Phillips AD.

Microbes Infect. 2006 Jun;8(7):1741-9. Epub 2006 May 2.

PMID:
16815722
47.

Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo.

Miyamoto Y, Iimura M, Kaper JB, Torres AG, Kagnoff MF.

Cell Microbiol. 2006 May;8(5):869-79.

PMID:
16611235
48.

The lpf gene cluster for long polar fimbriae is not involved in adherence of enteropathogenic Escherichia coli or virulence of Citrobacter rodentium.

Tatsuno I, Mundy R, Frankel G, Chong Y, Phillips AD, Torres AG, Kaper JB.

Infect Immun. 2006 Jan;74(1):265-72.

49.

Pathogenic Escherichia coli.

Kaper JB.

Int J Med Microbiol. 2005 Oct;295(6-7):355-6. No abstract available.

PMID:
16238012

Supplemental Content

Loading ...
Support Center